Boceprevir Capsules

Products Affected - Description

Victrelis oral capsule, Merck
200 mg, 28 bottles 12 count (NDC 00085-0314-02)

Reason for the Shortage

• Merck Sharp & Dohme has made a business decision to discontinue Victrelis capsules in the US by December 2015.
• Merck Sharp & Dohme is the sole supplier of boceprevir capsules.
  

Available Products

There is insufficient supply for usual ordering.

Estimated Resupply Dates

Merck Sharp & Dohme Victrelis 200 mg capsules available with an expiration date of December 2015. The company is discontinuing the product by December 2015.

Related Shortages

• Acetylcholine Chloride Powder for Intraocular Solution — Current
• Becaplermin Gel — Resolved
• Cardioplegic Solution for Cardiac Perfusion — Current
• Castor Oil, Balsam Peru, and Trypsin Topical Products — No Longer Available
• Chloroquine Tablets — Current
• Dexpanthenol Injection — Current
• Diatrizoate Meglumine 66% and Diatrizoate Sodium 10% — Resolved
• Erythromycin Ethylsuccinate and Sulfisoxazole Oral Suspension — No Longer Available
• Ezetimibe and Atorvastatin Tablets — No Longer Available
• Fluticasone/Salmeterol Inhalation Aerosol (Advair HFA) — Resolved
• Gabapentin Enacarbil Extended Release Tablets — Resolved
• Gadoteridol Injection — Current
• Hydroxychloroquine Sulfate Tablets — Resolved
• Iopamidol Injection — Resolved
• Levothyroxine (Levothroid) Oral Tablets — No Longer Available
• Otic Unapproved Prescription Preparations Containing Benzocaine or Chloroxylenol — No Longer Available
• Prenatal Multivitamins with Minerals — No Longer Available
• Rifampin and Isoniazid Capsules — Resolved
• Trypan Blue 0.15% Ophthalmic Solution — Resolved
• Warfarin for Injection — No Longer Available

Updated

December 9, June 25, January 20, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.